Visumab 0.5mg Injection
Prescription Required
Product introduction
Visumab 0.5mg Injection is used for the treatment of eye diseases which are caused by diabetes, macular degeneration, and macular swelling. It reduces the abnormal growth and leakage of blood vessels in the eye that can cause vision loss.
Visumab 0.5mg Injection is administered directly into the eyeball by an eye specialist. You should not self administer this medicine at home. The common side effects include conjunctival hemorrhage, eye pain, eye floaters, increased intraocular pressure, and eye inflammation.
However, if you experience these side effects for a longer duration or any other symptoms which you think may be due to this medicine, please inform your doctor. It is not advised to drive after administration of this injection as it may cause blurring of vision.
Visumab 0.5mg Injection is administered directly into the eyeball by an eye specialist. You should not self administer this medicine at home. The common side effects include conjunctival hemorrhage, eye pain, eye floaters, increased intraocular pressure, and eye inflammation.
However, if you experience these side effects for a longer duration or any other symptoms which you think may be due to this medicine, please inform your doctor. It is not advised to drive after administration of this injection as it may cause blurring of vision.
Uses of Visumab Injection
- Diabetic eye disease
- Wet age-related macular degeneration
- Macular edema due to retinal vein occlusion
Side effects of Visumab Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Visumab
- Conjunctival hemorrhage
- Eye pain
- Increased intraocular pressure
- Foreign body sensation in eyes
- Blurred vision
- Nausea
- Dry eye
- Eye itching
- Cataract
- Vitreous floaters
- Vitreous detachment
- Intraocular inflammation
- Eye irritation
- Increased lacrimation
- Eyelid inflammation
- Ocular hyperemia
- Retinal disorder
- Maculopathy
- Eye discomfort
- Posterior capsule opacification
- Injection site hemorrhage
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Anemia (low number of red blood cells)
- Joint pain
- Renal failure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Gastro-esophageal reflux disease
- Hypercholesterolemia (high cholesterol)
- Bronchitis (inflammation of the airways)
How to use Visumab Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Visumab Injection works
Visumab 0.5mg Injection is a monoclonal antibody. It works in cancer by stopping the formation of blood vessels that bring oxygen and nutrients to cancerous cells. This may slow the growth and spread of cancer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Visumab 0.5mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Visumab 0.5mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Visumab 0.5mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Visumab 0.5mg Injection may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Kidney
SAFE IF PRESCRIBED
Visumab 0.5mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Visumab 0.5mg Injection may not be needed in these patients. Please consult your doctor.
Liver
SAFE IF PRESCRIBED
Visumab 0.5mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Visumab 0.5mg Injection may not be needed in these patients. Please consult your doctor.
What if you forget to take Visumab Injection?
If you miss a dose of Visumab 0.5mg Injection, please consult your doctor.\n
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Visumab 0.5mg Injection
₹14543/Injection
Lucentis Injection
Novartis India Ltd
₹70160/injection
368% costlier
Razumab 0.5mg Injection
Intas Pharmaceuticals Ltd
₹70160/injection
368% costlier
Ranizurel 0.5mg Injection
Reliance Life Sciences
₹19990/injection
33% costlier
Quick tips
- It may cause temporary visual disturbances. Don't drive or do anything that requires mental focus until you know how Visumab 0.5mg Injection affects you.
- Inform your doctor if you experience increased eye pain and redness, blurred or decreased vision, or increased sensitivity to light.
- Wear sunglasses if your eyes feel sensitive to light
- Use eye drops if they are prescribed to you by your doctor.
- Ask your doctor if you should avoid any particular activities.
- Try to rest your eyes as much as possible (for at least a few hours).
Fact Box
Chemical Class
Monoclonal antibody (mAb)
Habit Forming
No
Therapeutic Class
OPHTHAL
Action Class
Vascular endothelial growth factor (VEGF) inhibitor for AMD
Interaction with drugs
Taking Visumab with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Concurrent use may increase the risk of bleeding.
If concurrent use is essential, watch out for bleeding and consult your doctor immediately.
Concurrent use may increase the risk of bleeding.
If concurrent use is essential, watch out for bleeding and consult your doctor immediately.
Concurrent use may increase the risk of bleeding.
If concurrent use is essential, watch out for bleeding and consult your doctor immediately.
Concurrent use may increase the risk of bleeding.
If concurrent use is essential, watch out for bleeding and consult your doctor immediately.
Concurrent use may increase the risk of bleeding.
If concurrent use is essential, watch out for bleeding and consult your doctor immediately.
Patient concerns
FAQs
How is Visumab 0.5mg Injection administered?
Visumab 0.5mg Injection is to be administered by intravitreal (into the eye) injection once a month. Your doctor will use a medicine to numb your eye before giving you the injection. You will receive this injection in a hospital or clinic setting.
Can Visumab 0.5mg Injection cause eye redness and pain?
Yes, some of the common side effects of Visumab 0.5mg Injection are eye redness, sensitivity to light, pain, and abnormal vision. Seek immediate medical help in such cases.
Who should not take Visumab 0.5mg Injection?
Visumab 0.5mg Injection should not be taken by individuals who are allergic to the medication or have an active eye infection.
What is the duration of treatment for Visumab 0.5mg Injection?
Visumab 0.5mg Injection is recommended to be initially administered by intravitreal injection (into the eye) once a month (approximately 28 days) for up to 3 months.
What precautions should I take after taking Visumab 0.5mg Injection?
After taking Visumab 0.5mg Injection:<br>a. You should not wash your face and hair or shower for 48 hours<br>b. Avoid rubbing your eyes<br>c. Avoid swimming for a week. Consult your doctor in case of any doubts<br>d. Do not wear contact lenses immediately after injection. You may wear spectacles instead<br>e. Give complete rest to your eyes and do not strain by looking at television, mobile phones, or computer screens for 1-2 days.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Henderer JD, Rapuano CJ. Ocular Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1794.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1196-97.
- Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 977.
- Drugs.com. Ranibizumab. [Accessed 04 Apr. 2019] (online) Available from:
- Ranibizumab. South San Francisco, California: Genentech, Inc.; 2006. [Accessed 23 Jan. 2019] (online) Available from:
- Ranibizumab. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2007 [revised 26 Jul. 2018]. [Accessed 04 Apr. 2019] (online) Available from:
Marketer details
Name: Reliance Life Sciences
Address: Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane-Belapur Road, Rabale, Navi Mumbai 400 701
Country of origin: India
Lab tests offered by us
Related/Popular tests
₹14543
Inclusive of all taxes
MRP₹15000 3% OFF
1.0 Injection in 1 vial
SOLD OUT
Notify me
